3 Best Stocks to Buy Now, 8/25/2025, According to Top Analysts

Wall Street's sharpest minds just dropped their hottest picks—and these three stocks are screaming 'buy' right now.

Analysts' Top Picks Revealed

The smart money's piling into these names before the next rally hits. No fluff, no maybes—just straight conviction calls from the pros who actually get paid to be right.

Timing the Market Perfectly

Forget waiting for dips—these stocks are primed for immediate momentum. Because let's be honest, most investors miss the entry while overanalyzing charts that even the analysts ignore.

Why These Three Stand Out

Sector dominance, insane growth trajectories, and balance sheets that don't rely on creative accounting. Unlike some 'innovative' fintech plays that are just debt with a fancy app.

Get positioned before the herd catches on—because on Wall Street, the early bird doesn't just get the worm, it gets the whole damn buffet while everyone else fights for crumbs.

Elevate Your Investing Strategy:

• Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. 

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.

(CLDX)– Celldex Therapeutics is a biopharmaceutical company developing targeted therapies for cancer and immune-related diseases. On Saturday, LifeSci Capital analyst Sam Slutsky maintained a Buy rating on the stock with a price target of $61 per share. In the last three months, all seven Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 145.8%.

(RBLX) – Roblox is an online gaming and creation platform that allows users to play, create, and share interactive 3D experiences. On Friday, Wolfe Research analyst Shweta Khajuria upgraded the stock to Buy from Hold with a price target of $150. The analyst expects Roblox to benefit from “platform flywheel effects,” including search and discovery improvements and faster content velocity. Interestingly, 15 out of the 18 Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 24.94%. 

(BHVN)– Biohaven Ltd. is a biopharmaceutical company focused on developing therapies for neurological and rare diseases. On Friday, William Blair analyst Myles Minter maintained a Buy rating on the stock. Interestingly, six out of the seven Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 174.4%. 

Who Are the Top Analysts? 

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. 

See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page. 

Disclosure